Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Rapid HTAs of three medical devices released in Tuscany

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Below is the list of technologies that have been assessed:

  • Fixation/dissection instrument Ligasure Exact by Covidien for open surgical operations in patients with benign and malignant nodular thyroid disease;
  • Blade-plate for osteosynthesis Synthes Blade-plate by DePuy Synthes for patients with a pathology requiring a realignment and stabilization procedure limited to the distal or proximal femur;
  • Vascular access system (consisting of catheter and controller) Ellipsys by Avenu Medical for patients who are to undergo dialysis but for whom the creation of a fistula cannot be performed either surgically or through the use of WavelinQ system.

See the regional decree and all assessments in Italian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.